Jeremy Levin has seen the biopharma industry from practically every vantage point. Now, with decades of experience under his belt, he’s out front in the chorus of veterans sounding the alarm about threats to US dominance in biotech. He joins Post-Hoc Live to talk about China, US policy, and how to stem the bleeding.
Stay ahead of biopharma. Get the Main Edition in your inbox M-F at 11:30 AM ET. Sign up: https://shorturl.at/OBB3D
Podden och tillhörande omslagsbild på den här sidan tillhör
Endpoints News. Innehållet i podden är skapat av Endpoints News och inte av,
eller tillsammans med, Poddtoppen.
